Please enable JS

Clinica Groupe

Founded in 2007, Clinica Group has an experience in interventional, observational and pharmaco-epidemiological management studies, in different therapeutic areas, which helped them meet their customers’ various needs and place their satisfaction at the center  of their business.

Their employees work in accordance with international standards (Declaration of Helsinki, ICH-GCP etc.) in order to meet their pharmaceutical and institutional partners’ expectations.

Their main goals are the quality of their activity, the satisfaction of their customers, and the adherence to ethical values.

 

Learn more: www.clinicagroup.com

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

What role does AI play in lung cancer screening?

December 13, 2025

Mind Health With 53,000 new cases diagnosed each year, lung cancer is the deadliest cancer in France, according to data from the National Cancer Institute. Three-quarters of cases are detected at an advanced stage, which reduces the chances of recovery. The importance of screening is therefore crucial. In this field, the combination of low-dose CT […]

READ MORE
telemedecine technologies news

Quality Isn’t Just a Checkbox — Can Better Workforce Skills Drive Lower Costs?

November 27, 2025

Med City News Healthcare quality isn’t improving at scale, despite advances in technology, because many systems treat it as another compliance task rather than a priority. Stephanie Mercado, CEO of the National Association for Healthcare Quality (NAHQ), argued that investing in workforce skills and standardizing roles can drive safer, higher-quality care while delivering measurable cost […]

READ MORE
telemedecine technologies news

Truth in Reporting Clinical Trial Efficacy: A Call for Action

November 27, 2025

Trial Site News Clinical trial reporting of treatment efficacy is the foundation of public trust in medicine. Yet pharmaceutical companies often report efficacy measured as a relative risk reduction (RRR) while omitting the more relevant absolute risk reduction (ARR). This statistical sleight of hand can make clinically insignificant benefits look spectacular! Consider a simple example A risk is […]

READ MORE